Merck & Co., Inc. is a global leader in the healthcare industry, operating through pharmaceutical and animal health segments. The company has a strong presence in various therapeutic areas and a robust pipeline of innovative treatments. Its strategic collaborations further enhance its potential for growth.
Merck & Co., Inc. shows strong financial health with impressive fundamental scores in key areas, indicating a stable investment opportunity.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow (DCF) | 5 | |
| Return on Equity (ROE) | 5 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 3 | |
| Price to Book (P/B) | 2 |
The ratings history shows consistent performance, underscoring Merck's ability to maintain financial stability.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-04 | 4 | 5 | 5 | 5 | 1 | 3 | 2 |
| Historical Date | 0 | 5 | 5 | 5 | 1 | 3 | 2 |
Analysts are optimistic about Merck's future, with a consensus target above the current market price.
| High | Low | Median | Consensus |
|---|---|---|---|
| 136 | 90 | 122 | 119.91 |
The sentiment analysis shows a strong inclination towards buying the stock, reflecting confidence in Merck's potential.
| Recommendation | Number | Distribution |
|---|---|---|
| Buy | 25 | |
| Hold | 10 | |
| Sell | 1 |
Merck & Co., Inc. presents potential as a robust investment due to its strong market position in healthcare and solid financial metrics. While there are risks associated with market competition and regulatory changes, the company’s innovative pipeline and strategic collaborations enhance its growth prospects. Meanwhile, analysts maintain an optimistic outlook, reflecting confidence in sustained profitability. Investors should consider market conditions and ongoing developments in the healthcare industry before making a decision.